Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Low back pain can be seen in every period of life. More than 80 percent of the society complain of low back pain at any time of life. Although the frequency of applying to a health institution due to low back pain varies from one society to the other, it takes place in the first three places in each community. Low back pain should be differentiated as new (acute) and long-term (chronic). In the treatment of chronic low back pain, rest, education, pharmacological treatment, physical therapy, painful point injections, surgical interventions, kinesio taping can be applied. The most frequently used physical therapy modalities for treatment of chronic low back pain are superficial and deep heat modalities (hot pack, infrared, ultrasound, microwave diathermy radar) and analgesic effective electrotherapy (TENS, interferential flows) modalities. One of the most important treatments is exercise therapy. In cases where conventional treatment of chronic low back pain is insufficient, that is, the patient's pain is still ongoing and functional recovery is insufficient, some alternative methods are also applied. These treatments include ozone, prolotherapy injection applications, dry needling, acupuncture, phytotherapy, balneotherapy, kinesio taping and so on. The aim of this study is to compare the efficacy of painful point injection and kinesio taping treatments in lumbar region in patients with chronic low back pain.
Approximately 84 volunteer patients will be included in the study, patients older than 18 years, under 75 years of age, with a minimum of 3 months of mechanical back pain, Visual Analog Scale score of at least 60 patients will be included. Who are older than 18 years of age, having mental problems, having peripheral problems affecting the central nervous system, having received physical therapy to the lumbar region in the last 3 months, having been applied to the lumbar region within the last 3 months, having a history of lumbar region surgery, having a history of patients with motor deficit in the extremity, needle phobia, lidocaine and / or kinesio tape allergy, patients with wound, infection, burn, allergic lesions in the application area will not be included.
Patients included in the study will be included in the first (first), second (second), third (third) or fourth (fourth) treatment group by random number generator method.
The first group will be given the hot package (20 minutes / day) + exercise + 1. 4. 7. 10. 13. 16. days.
The second group will be given a hot package (20 minutes / day) + exercise + 1. 4. 7. 10. 13. 16 days.
The third group hot package (20 minutes / day) + exercise + 1. 4. 7. 10. 13. 16. days, kinesio tape will be applied to the determined areas.
the fourth group hot package (20 minutes / day) + exercise + 1. 4. 7. 10. 13. 16. days sham tape application will be made in the regions determined. ****
Patients in all groups will continue to use the hotpack and exercises until the 3rd month after the first day of their study. First session exercises with the same physiotherapist (stretching for back-waist, iliopsoas and hamstring muscles; exercise range of hip and waist; hip and waist isometric exercises). Each patient will do the exercises 20 minutes after the hot package application.
saline and local anesthetic injection points to be applied to the lumbar region:
Future points on spinous projections from L1 to L5
Lumbar region 2 from the middle point of the spinous output bilateral and 2 cm to 4 cm lateral points
To each point of the iliac lobe of iliac crest will be injected subcutaneously with 0.5 ml 0.5% lidocaine-containing local anesthetic.
6 mm 30 gauge needle tip will be used for injection.
For each patient who underwent subcutaneous local anesthetic, an average of 18-20 ml of 0.5% lidocaine-containing local anesthetic and 18-20 ml of 0.09% NaCl-containing isotonic saline will be used for each patient.
These points are the points of quadle technique applied in neural therapy.
Kinesio taping will use 2 cut-to-length I-bands with a length of about 15 cm long for one patient. Space correction technique will be used for patients. The lumbar region of the patients will be glued vertically to the paravertebral muscles vertically 3-4 cm lateral to the spinous projections. As a starting point for patients, S1 will be adhered to the vertebra without tension, then the patient will be asked to come with maximum lumbar flexion posterior.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| kinesio taping | Experimental | two 15 cm I type kinesio tape applied longitudinally |
|
| sham kinesio taping | Placebo Comparator | two 15 cm I type kinesio tape applied longitudinally but without stretching |
|
| local anesthetic | Experimental | 18-20 cc %0.5 lidocaine subcutaneous injection |
|
| local serum physiologic | Placebo Comparator | 18-20 cc % 0.09 NaCl subcutaneous injection |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| kinesio tape | Other | two 15 cm I type kinesio tape applied longitudinally |
|
| Measure | Description | Time Frame |
|---|---|---|
| Pain Severity: Visual Analog Scale | visual analog scale: minimum score: 0 maximum score: 10. Higher scores reflect more severe pain | day 0 (before intervention) |
| Pain Severity: Visual Analog Scale | visual analog scale: minimum score: 0 maximum score: 10. Higher scores reflect more severe pain | day 16 (after 6th application) |
| Pain Severity: Visual Analog Scale | visual analog scale: minimum score: 0 maximum score: 10. Higher scores reflect more severe pain | 1 month after intervention |
| Pain Severity: Visual Analog Scale | visual analog scale: minimum score: 0 maximum score: 10. Higher scores reflect more severe pain | 3 months after intervention |
| Measure | Description | Time Frame |
|---|---|---|
| Disability Severity: Oswestry Disabiliy Index | Oswestry Disabiliy Index: minimum score: 0 maximum score: 50. Higher scores reflect more severe disability | day 0 (before intervention) |
| Disability Severity: Oswestry Disability Index |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| ADEM ERBİROL | sultan abdulhamid han | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Sultan 2.Abdülhamid Han Training and Research Hospital | Istanbul | Eyalet/Yerleşke | 34000 | Turkey (Türkiye) | ||
other researchers would get information from the main researcher. therefore it was not shared.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Kinesio Taping | two 15 cm I type kinesio tape applied longitudinally kinesio tape: two 15 cm I type kinesio tape applied longitudinally |
| FG001 | Sham Kinesio Taping | two 15 cm I type kinesio tape applied longitudinally but without stretching kinesio tape: two 15 cm I type kinesio tape applied longitudinally |
| FG002 | Local Anesthetic | 18-20 cc %0.5 lidocaine subcutaneous injection local anesthetic: local anesthetic: 18-20 cc %0.5 lidocaine subcutaneous injection |
| FG003 | Local Serum Physiologic | 18-20 cc % 0.09 NaCl subcutaneous injection local serum physiologic: serum physiologic : 18-20 cc % 0.09 NaCl subcutaneous injection |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Kinesio Taping | two 15 cm I type kinesio tape applied longitudinally kinesio tape: two 15 cm I type kinesio tape applied longitudinally |
| BG001 | Sham Kinesio Taping | two 15 cm I type kinesio tape applied longitudinally but without stretching kinesio tape: two 15 cm I type kinesio tape applied longitudinally |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Categorical | Count of Participants |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Pain Severity: Visual Analog Scale | visual analog scale: minimum score: 0 maximum score: 10. Higher scores reflect more severe pain | intent to treat population(all participants) | Posted | Mean | Standard Deviation | score on a scale | day 0 (before intervention) |
|
adverse events were not monitored/assessed
adverse events were not monitored/assessed
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Kinesio Tape | two 15 cm I type kinesio tape applied longitudinally | 0 |
Not provided
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Adem Erbirol | SultanAbdulhamid | +905426608788 | aerbirol@hotmail.com |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Aug 1, 2019 | Jun 17, 2020 | Prot_SAP_000.pdf |
Not provided
| ID | Term |
|---|---|
| D055052 | Athletic Tape |
| D000779 | Anesthetics, Local |
| ID | Term |
|---|---|
| D001458 | Bandages |
| D004864 | Equipment and Supplies |
| D009989 | Orthotic Devices |
| D009983 | Orthopedic Equipment |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| local anesthetic | Other | local anesthetic: 18-20 cc %0.5 lidocaine subcutaneous injection |
|
| local serum physiologic | Other | serum physiologic : 18-20 cc % 0.09 NaCl subcutaneous injection |
|
Oswestry Disabiliy Index:
minimum score: 0 maximum score: 50. Higher scores reflect more severe disability
| day 16 (after 6th application) |
| Disability Severity: Oswestry Disability Index | Oswestry Disabiliy Index: minimum score: 0 maximum score: 50. Higher scores reflect more severe disability | 1 month after intervention |
| Disability Severity: Oswestry Disability Index | Oswestry Disabiliy Index: minimum score: 0 maximum score: 50. Higher scores reflect more severe disability | 3 months after intervention |
| Patient Reported Quality of Life: Short Form 36 Physical Functioning | short form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. short form 36 physical functioning subscale scores are given. minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life | day 0 (before intervention) |
| Patient Reported Quality of Life: Short Form 36 Physical Functioning | short form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. short form 36 physical functioning subscale scores are given. minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life | day 16 (after 6th application) |
| Patient Reported Quality of Life: Short Form 36 Physical Functioning | short form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. short form 36 physical functioning subscale scores are given. minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life | 1 month after intervention |
| Patient Reported Quality of Life: Short Form 36 Physical Functioning | short form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. short form 36 physical functioning subscale scores are given. minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life | 3 months after intervention |
| Spinal Mobility: Schober Test | Schober's test is classically used to determine if there is a decrease in lumbar spine range of motion (flexion). Patient is standing, examiner marks the L5 spinous process by drawing a horizontal line across the patients back. A second line is marked 10 cm above the first line. Patient is then instructed to flex forward as if attempting to touch his/her toes, examiner remeasures distance between two lines with patient fully flexed. The difference between the measurements in erect and flexion positions indicates the outcome of the lumbar flexion. Less than 5cm increase in length with forward flexion: Decreased lumbar spine range of motion. | day 0 (before intervention) |
| Spinal Mobility: Schober Test | Schober's test is classically used to determine if there is a decrease in lumbar spine range of motion (flexion). Patient is standing, examiner marks the L5 spinous process by drawing a horizontal line across the patients back. A second line is marked 10 cm above the first line. Patient is then instructed to flex forward as if attempting to touch his/her toes, examiner remeasures distance between two lines with patient fully flexed. The difference between the measurements in erect and flexion positions indicates the outcome of the lumbar flexion. Less than 5cm increase in length with forward flexion: Decreased lumbar spine range of motion. | day 16 (after 6th application) |
| Spinal Mobility: Schober Test | Schober's test is classically used to determine if there is a decrease in lumbar spine range of motion (flexion). Patient is standing, examiner marks the L5 spinous process by drawing a horizontal line across the patients back. A second line is marked 10 cm above the first line. Patient is then instructed to flex forward as if attempting to touch his/her toes, examiner remeasures distance between two lines with patient fully flexed. The difference between the measurements in erect and flexion positions indicates the outcome of the lumbar flexion. Less than 5cm increase in length with forward flexion: Decreased lumbar spine range of motion. | 1 month after intervention |
| Spinal Mobility: Schober Test | Schober's test is classically used to determine if there is a decrease in lumbar spine range of motion (flexion). Patient is standing, examiner marks the L5 spinous process by drawing a horizontal line across the patients back. A second line is marked 10 cm above the first line. Patient is then instructed to flex forward as if attempting to touch his/her toes, examiner remeasures distance between two lines with patient fully flexed. The difference between the measurements in erect and flexion positions indicates the outcome of the lumbar flexion. Less than 5cm increase in length with forward flexion: Decreased lumbar spine range of motion. | 3 months after intervention |
| Patient Reported Quality of Life: Short Form-36 Mental Health | Short Form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. Short Form-36 Mental health subscale scores are given. Mental minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life. | day 0 before intervention |
| Patient Reported Quality of Life: Short Form-36 Mental Health | Short Form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. Short Form-36 Mental health subscale scores are given. Mental minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life. | day 16 (after 6th application) |
| Patient Reported Quality of Life: Short Form-36 Mental Health | Short Form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. Short Form-36 Mental health subscale scores are given. Mental minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life. | 1 month after intervention |
| Patient Reported Quality of Life: Short Form-36 Mental Health | Short Form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. Short Form-36 Mental health subscale scores are given. Mental minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life. | 3 months after intervention |
| Sultan Abdülhamid Han Training and Research Hospital |
| Istanbul |
| Eyalet/Yerleşke |
| 34000 |
| Turkey (Türkiye) |
| BG002 | Local Anesthetic | 18-20 cc %0.5 lidocaine subcutaneous injection local anesthetic: local anesthetic: 18-20 cc %0.5 lidocaine subcutaneous injection |
| BG003 | Local Serum Physiologic | 18-20 cc % 0.09 NaCl subcutaneous injection local serum physiologic: serum physiologic : 18-20 cc % 0.09 NaCl subcutaneous injection |
| BG004 | Total | Total of all reporting groups |
| Participants |
|
| Age, Continuous | Mean | Standard Deviation | years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Race (NIH/OMB) | Count of Participants | Participants |
|
| Region of Enrollment | Number | participants |
|
| Body Mass Index | Mean | Standard Deviation | kg/m2 |
|
| OG002 | Local Anesthetic | 18-20 cc %0.5 lidocaine subcutaneous injection local anesthetic: local anesthetic: 18-20 cc %0.5 lidocaine subcutaneous injection |
| OG003 | Local Serum Physiologic | 18-20 cc % 0.09 NaCl subcutaneous injection local serum physiologic: serum physiologic : 18-20 cc % 0.09 NaCl subcutaneous injection |
|
|
| Primary | Pain Severity: Visual Analog Scale | visual analog scale: minimum score: 0 maximum score: 10. Higher scores reflect more severe pain | intent to treat population(all participants) | Posted | Mean | Standard Deviation | score on a scale | day 16 (after 6th application) |
|
|
|
| Primary | Pain Severity: Visual Analog Scale | visual analog scale: minimum score: 0 maximum score: 10. Higher scores reflect more severe pain | intent to treat population(all participants) | Posted | Mean | Standard Deviation | score on a scale | 1 month after intervention |
|
|
|
| Primary | Pain Severity: Visual Analog Scale | visual analog scale: minimum score: 0 maximum score: 10. Higher scores reflect more severe pain | intent to treat population(all participants) | Posted | Mean | Standard Deviation | score on a scale | 3 months after intervention |
|
|
|
| Secondary | Disability Severity: Oswestry Disabiliy Index | Oswestry Disabiliy Index: minimum score: 0 maximum score: 50. Higher scores reflect more severe disability | intent to treat population(all participants) | Posted | Mean | Standard Deviation | score on a scale | day 0 (before intervention) |
|
|
|
| Secondary | Disability Severity: Oswestry Disability Index | Oswestry Disabiliy Index: minimum score: 0 maximum score: 50. Higher scores reflect more severe disability | intent to treat population(all participants) | Posted | Mean | Standard Deviation | score on a scale | day 16 (after 6th application) |
|
|
|
| Secondary | Disability Severity: Oswestry Disability Index | Oswestry Disabiliy Index: minimum score: 0 maximum score: 50. Higher scores reflect more severe disability | intent to treat population(all participants) | Posted | Mean | Standard Deviation | score on a scale | 1 month after intervention |
|
|
|
| Secondary | Disability Severity: Oswestry Disability Index | Oswestry Disabiliy Index: minimum score: 0 maximum score: 50. Higher scores reflect more severe disability | intent to treat population(all participants) | Posted | Mean | Standard Deviation | score on a scale | 3 months after intervention |
|
|
|
| Secondary | Patient Reported Quality of Life: Short Form 36 Physical Functioning | short form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. short form 36 physical functioning subscale scores are given. minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life | intent to treat population(all participants) | Posted | Mean | Standard Deviation | score on a scale | day 0 (before intervention) |
|
|
|
| Secondary | Patient Reported Quality of Life: Short Form 36 Physical Functioning | short form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. short form 36 physical functioning subscale scores are given. minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life | intent to treat population(all participants) | Posted | Mean | Standard Deviation | score on a scale | day 16 (after 6th application) |
|
|
|
| Secondary | Patient Reported Quality of Life: Short Form 36 Physical Functioning | short form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. short form 36 physical functioning subscale scores are given. minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life | intent to treat population(all participants) | Posted | Mean | Standard Deviation | score on a scale | 1 month after intervention |
|
|
|
| Secondary | Patient Reported Quality of Life: Short Form 36 Physical Functioning | short form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. short form 36 physical functioning subscale scores are given. minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life | intent to treat population(all participants) | Posted | Mean | Standard Deviation | score on a scale | 3 months after intervention |
|
|
|
| Secondary | Spinal Mobility: Schober Test | Schober's test is classically used to determine if there is a decrease in lumbar spine range of motion (flexion). Patient is standing, examiner marks the L5 spinous process by drawing a horizontal line across the patients back. A second line is marked 10 cm above the first line. Patient is then instructed to flex forward as if attempting to touch his/her toes, examiner remeasures distance between two lines with patient fully flexed. The difference between the measurements in erect and flexion positions indicates the outcome of the lumbar flexion. Less than 5cm increase in length with forward flexion: Decreased lumbar spine range of motion. | intent to treat population(all participants) | Posted | Mean | Standard Deviation | centimeters | day 0 (before intervention) |
|
|
|
| Secondary | Spinal Mobility: Schober Test | Schober's test is classically used to determine if there is a decrease in lumbar spine range of motion (flexion). Patient is standing, examiner marks the L5 spinous process by drawing a horizontal line across the patients back. A second line is marked 10 cm above the first line. Patient is then instructed to flex forward as if attempting to touch his/her toes, examiner remeasures distance between two lines with patient fully flexed. The difference between the measurements in erect and flexion positions indicates the outcome of the lumbar flexion. Less than 5cm increase in length with forward flexion: Decreased lumbar spine range of motion. | intent to treat population(all participants) | Posted | Mean | Standard Deviation | centimeters | day 16 (after 6th application) |
|
|
|
| Secondary | Spinal Mobility: Schober Test | Schober's test is classically used to determine if there is a decrease in lumbar spine range of motion (flexion). Patient is standing, examiner marks the L5 spinous process by drawing a horizontal line across the patients back. A second line is marked 10 cm above the first line. Patient is then instructed to flex forward as if attempting to touch his/her toes, examiner remeasures distance between two lines with patient fully flexed. The difference between the measurements in erect and flexion positions indicates the outcome of the lumbar flexion. Less than 5cm increase in length with forward flexion: Decreased lumbar spine range of motion. | intent to treat population(all participants) | Posted | Mean | Standard Deviation | centimeters | 1 month after intervention |
|
|
|
| Secondary | Spinal Mobility: Schober Test | Schober's test is classically used to determine if there is a decrease in lumbar spine range of motion (flexion). Patient is standing, examiner marks the L5 spinous process by drawing a horizontal line across the patients back. A second line is marked 10 cm above the first line. Patient is then instructed to flex forward as if attempting to touch his/her toes, examiner remeasures distance between two lines with patient fully flexed. The difference between the measurements in erect and flexion positions indicates the outcome of the lumbar flexion. Less than 5cm increase in length with forward flexion: Decreased lumbar spine range of motion. | intent to treat population(all participants) | Posted | Mean | Standard Deviation | centimeters | 3 months after intervention |
|
|
|
| Secondary | Patient Reported Quality of Life: Short Form-36 Mental Health | Short Form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. Short Form-36 Mental health subscale scores are given. Mental minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life. | intent to treat population(all participants) | Posted | Mean | Standard Deviation | score on a scale | day 0 before intervention |
|
|
|
| Secondary | Patient Reported Quality of Life: Short Form-36 Mental Health | Short Form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. Short Form-36 Mental health subscale scores are given. Mental minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life. | intent to treat population(all participants) | Posted | Mean | Standard Deviation | score on a scale | day 16 (after 6th application) |
|
|
|
| Secondary | Patient Reported Quality of Life: Short Form-36 Mental Health | Short Form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. Short Form-36 Mental health subscale scores are given. Mental minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life. | intent to treat population(all participants) | Posted | Mean | Standard Deviation | score on a scale | 1 month after intervention |
|
|
|
| Secondary | Patient Reported Quality of Life: Short Form-36 Mental Health | Short Form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. Short Form-36 Mental health subscale scores are given. Mental minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life. | intent to treat population(all participants) | Posted | Mean | Standard Deviation | score on a scale | 3 months after intervention |
|
|
|
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| EG001 | Sham Kinesio Taping | two 15 cm I type kinesio tape applied longitudinally but without stretching | 0 | 0 | 0 | 0 | 0 | 0 |
| EG002 | Local Anesthetic | 18-20 cc %0.5 lidocaine subcutaneous injection | 0 | 0 | 0 | 0 | 0 | 0 |
| EG003 | Local Serum Physiologic | 18-20 cc % 0.09 NaCl subcutaneous injection | 0 | 0 | 0 | 0 | 0 | 0 |
Not provided
Not provided
| D013523 |
| Surgical Equipment |
| D000777 | Anesthetics |
| D002492 | Central Nervous System Depressants |
| D045505 | Physiological Effects of Drugs |
| D020228 | Pharmacologic Actions |
| D020164 | Chemical Actions and Uses |
| D018689 | Sensory System Agents |
| D018373 | Peripheral Nervous System Agents |
| D002491 | Central Nervous System Agents |
| D045506 | Therapeutic Uses |